Is the price fair?
What CVS's price assumes
CVS Health trades at 24.8× earnings against 25.3× for the median Healthcare Plans name, cheaper than its own group.
24.8
Trailing P/E · Healthcare Plans median 25.3 · cheaper than the typical name in its group
- Price / sales
- 0.22
Price / sales · as of 2026-Q1
- Free cash flow yield
- 9.4%
Free cash flow yield · Healthcare Plans median 6.5%
- Growth the price implies
- −2.8%
Growth the price implies · The price pays for −2.8% free cash flow growth a year for a decade; the business has delivered −13% a year over the last three.
Details›
- Price / book2026-Q1
- 1.18
- EV / EBIToperating margin 2.0%: the multiple describes the denominator
- not meaningful
- Healthcare median P/E362 names
- 31.5
- Healthcare Plans median P/E11 names
- 25.3
- Free cash flow, trailing twelve months
- $11.8B
- Market capitalisation
- $125.4B
- 3-year revenue growth
- +7.0%
- 3-year free cash flow growth
- −13%
| Method | Per share |
|---|---|
| What its own history would imply | not meaningful, 75.5× today against a 12.9× median |
| 52-week range | $62.01 – $110.58 |
| Today | $94.30 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Healthcare Plans
Ranks #7 of 11 by Smart Score